Mobia Medical, Inc. (NASDAQ:MOBI) Stock Rated “Moderate Buy” by Sell-Side Brokerages

Mobia Medical, Inc. (NASDAQ:MOBI) has been given an average recommendation of “Moderate Buy” by the seven research firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $20.75.

MOBI has been the topic of several research reports. Weiss Ratings initiated coverage on shares of Mobia Medical in a research report on Wednesday, August 12th. They issued a “sell (e-)” rating on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Finally, BTIG Research reissued a “buy” rating and set a $19.00 target price on shares of Mobia Medical in a report on Tuesday, October 20th.

Insider Activity at Mobia Medical

In related news, Director Casey Tansey purchased 35,572 shares of Mobia Medical stock in a transaction dated Thursday, August 13th. The stock was bought at an average cost of $11.51 per share, for a total transaction of $409,433.72. Following the completion of the transaction, the director owned 268,904 shares in the company, valued at $3,095,085.04. This trade represents a 15.25% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders acquired 87,000 shares of company stock valued at $1,016,367 over the last three months.

Institutional Investors Weigh In On Mobia Medical

Several hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp bought a new position in shares of Mobia Medical in the second quarter valued at approximately $735,000. Citadel Advisors LLC purchased a new position in Mobia Medical during the second quarter valued at approximately $670,000. Finally, Readystate Asset Management LP bought a new stake in Mobia Medical during the 2nd quarter worth approximately $134,000.

Mobia Medical Stock Performance

Shares of MOBI opened at $11.27 on Friday. Mobia Medical has a fifty-two week low of $8.03 and a fifty-two week high of $15.29. The business has a 50-day moving average price of $10.02. The stock has a market cap of $375.18 million and a price-to-earnings ratio of -0.56. The company has a current ratio of 13.28, a quick ratio of 12.80 and a debt-to-equity ratio of 0.04.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($1.10) EPS for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The business had revenue of $13.51 million for the quarter. The company’s revenue was up 102.4% compared to the same quarter last year. As a group, research analysts predict that Mobia Medical will post -2.63 earnings per share for the current fiscal year.

About Mobia Medical

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.